Home | Jobs | Contact Us

                           

  WebCME
Joslin works with technology partners such as Medscape and i3 CME to deliver our CME activities on the Web so health professionals can participate at a time and place of their own choosing.  

 
 Joslin CME on Medscape
Participate in Joslin-sponsored Web-based CME hosted on the Medscape Web site.

»  Evolutions in Insulin Therapy: Current Perspectives on Treatment Design
Reviews the need for insulin in diabetes and discusses the design of appropriate, effective insulin programs, based on patient needs, barriers and challenges.

»  Glucose Control and Incretin Replacement: Achieving Therapeutic Impact
Explores the multiple pathophysiologic factors that cause type 2 diabetes, including incretin function and dysfunction, and outlines the newer mechanisms and resulting clinical strategies to target these factors.
»  Hyperglycemia and Dyslipidemia in Diabetes: Interrelationships and Interventions
Presents an evidence-based, and clinically relevant interpretation of the data supporting aggressive treatment of hyperglycemia and dyslipidemia to reduce the risk of cardiovascular disease in people with diabetes.
»  Hypogonadism and Type 2 Diabetes: Relationships and Clinical Perspectives
Reviews the epidemiology, prevalence, signs, and symptoms of hypogonadism as well as the associations with the metabolic syndrome/type 2 diabetes.
»  Renal Disease and Anemia: Interrelationships and Clinical Implications
Reviews the pathophysiology, progression, diagnosis, monitoring, and treatment of chronic kidney disease, hypertension, and anemia, and their potential cardiovascular impact in patients with diabetes.
»  Type 2 Diabetes and Cardiovascular Risk: Integrating Physician and Educator Perspectives
Reviews culturally diverse cases illustrating diabetes treatment strategies and the team approach encompassing physician and diabetes educator perspectives to achieve cardiovascular risk factor management goals.
»  Type 2 Diabetes - Restoring Glucose Homeostasis with Incretin Therapy: New Perspectives on Old Challenges
Reviews data and rationale on use of incretin-related therapies for type 2 diabetes using case scenarios that demonstrate potential strategies.
 
Privacy | Disclaimer | Site Map | Back to Top